Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $88.3 million.

  • Cellebrite DI's Operating Expenses rose 1668.08% to $88.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $334.0 million, marking a year-over-year increase of 1857.23%. This contributed to the annual value of $334.0 million for FY2025, which is 1857.23% up from last year.
  • Cellebrite DI's Operating Expenses amounted to $88.3 million in Q4 2025, which was up 1668.08% from $86.7 million recorded in Q3 2025.
  • Cellebrite DI's Operating Expenses' 5-year high stood at $88.3 million during Q4 2025, with a 5-year trough of $40.7 million in Q1 2021.
  • In the last 5 years, Cellebrite DI's Operating Expenses had a median value of $58.9 million in 2023 and averaged $63.2 million.
  • Per our database at Business Quant, Cellebrite DI's Operating Expenses soared by 6406.77% in 2021 and then plummeted by 69.38% in 2023.
  • Over the past 5 years, Cellebrite DI's Operating Expenses (Quarter) stood at $51.3 million in 2021, then grew by 1.85% to $52.2 million in 2022, then grew by 20.85% to $63.1 million in 2023, then rose by 19.97% to $75.7 million in 2024, then rose by 16.68% to $88.3 million in 2025.
  • Its last three reported values are $88.3 million in Q4 2025, $86.7 million for Q3 2025, and $81.2 million during Q2 2025.